Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
glykopyrrolat |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium adverse reaction |
Causative agent |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Allergy to glycopyrronium |
Causative agent |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide [antispasmodic] |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide [anesthesia] |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 200 mikrogram per milliliter, injektionsdos |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 600 mikrogram, injektionsdos 3 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrrolate 0.2mg/mL injection |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide 2 mg oral tablet |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide 1 mg oral tablet |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat för oralt bruk |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat för parenteralt bruk |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrrolate 100%w/w powder |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
neostigmin 2,5 mg + glykopyrron 500 mikrogram, injektionsvätska, lösning, ampull 1 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
neostigmin + glykopyrron |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 0,2 mg/ml, injektionsvätska, lösning, flaska 1 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 0,2 mg/ml, injektionsvätska, lösning, flaska 5 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 0,2 mg/ml, injektionsvätska, lösning, flaska 20 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 0,2 mg/ml, injektionsvätska, lösning, flaska 2 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 100 viktprocent, pulver |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide |
Is a |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide [anesthesia] |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide [antispasmodic] |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 600 mikrogram, injektionsdos 3 ml |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat 200 mikrogram per milliliter, injektionsdos |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Allergy to glycopyrronium |
Causative agent |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 2 mg oral tablet |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 1 mg oral tablet |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrronbromid och neostigminbromid |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
formoterol + glykopyrrolat |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat + indakaterol |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
formoterol + glykopyrrolat för inhalation |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
glykopyrrolat + indakaterol för inhalation |
Has active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
|
Glycopyrronium bromide 1 mg oral tablet |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 2 mg oral tablet |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 200 mikrogram/ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 200 mikrogram/ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 600 mikrogram/3 ml, injektionsvätska, lösning, ampull |
Has basis of strength substance (attribute) |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
glykopyrrolat 600 mikrogram/3 ml, injektionsvätska, lösning, ampull |
Has precise active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
2 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has precise active ingredient |
False |
Glycopyrronium bromide |
Inferred relationship |
Some |
2 |
Glycopyrronium bromide 200 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 200 microgram/mL solution for injection |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 160 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |
Product containing precisely glycopyrronium (as glycopyrronium bromide) 44 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
True |
Glycopyrronium bromide |
Inferred relationship |
Some |
1 |